Polarographic methods were used to examine oxidative phosphorylation in mitochondria isolated from hearts of rats treated with 5 mg/kg epinephrine, norepinephrine, or isoproterenol in oil given subcutaneously. Uncoupling of oxidative phosphorylation occurred (P/O ratio 2.1 ± .04 compared to P/O ratio of controls, 2.9 ± .03). Other indices of mitochondrial function, including oxygen consumption, respiratory control, adenosinetriphosphatase activity, and swelling were normal. The time course of depression of P/O ratio was parallel to that of myocardial catecholamine uptake, yet normal mitochondria were not affected by catecholamines in vitro ( I O^M ) . Adrenergic blocking agents in vitro did not improve the function of mitochondria from catecholaminetreated animals. No free fatty acids were detectable in extracts of mitochondria from either group by gas liquid chromatography, and the lipid profiles of extracts from each were similar by thin layer chromatography. The data indicate a means by which large quantities of exogenous or endogenous catecholamines could lead to increased oxygen consumption in vivo, or contribute to impairment of myocardial function.
• This investigation of the effect of catecholamines on oxidative metabolism of rat heart mitochondria was prompted by several previous observations. Large doses of catecholamines can produce an "oxygen-wasting" effect in animals (1) (2) (3) , and patients with pheochromocytoma usually have a markedly increased basal metabolic rate (4) . Heart mitochondria were chosen for study because large doses of catecholamines produce cardiomyopathy in laboratory animals (5) (6) (7) (8) and in man (9, 10) . We examined the effects of catecholamines on oxidative phosphorylation in mitochondria isolated from rat hearts when the catecholamines were administered in vivo and when they were added in vitro. When the animals were given catecholamines, oxidative phosphorylation in the mitochondria was im-From the Experimental Therapeutics Branch, National Heart Institute, Bethesda, Maryland.
Accepted for publication October 6, 1966. paired. However, mitochondria isolated from hearts of normal animals were not affected by catecholamines added in vitro. The mechanism of the catecholamine effect was investigated. The studies included determinations of myocardial catecholamine content following catecholamine administration both with and without preceding adrenergic blockade; blood pressure and blood gases in treated animals; oxidative phosphorylation in the presence of adrenergic blocking agents and other compounds in vitro; mitochondrial lipid content; mitochondrial adenosinetriphosphatase (ATPase) activity; and the degree of mitochondrial swelling. Although the precise mechanism could not be determined, the occurrence of impaired oxidative phosphorylation correlated well with elevated concentrations of myocardial catecholamines under a variety of circumstances.
In these studies, impaired oxidative phosphorylation was manifested by a decrease in the ratio of ^moles of adenosine triphosphate (ATP) produced to the /xatoms 1 of oxygen consumed by a mitochondrial preparation. This is called the P/O ratio. It has a theoretical maximum value of 3 when normal mitochondria are incubated with the substrates used in this study, and it is one index of mitochondrial efficiency. A depressed P/O ratio indicates a decreased ability of mitochondria to conserve the energy produced by substrate oxidation in a form that can be utilized by the cell (11) . Respiratory control (RC), another index of mitochondrial efficiency, is defined as the rate of respiration (oxygen consumption) of a mitochondrial preparation in the presence of a phosphate acceptor such as adenosine diphosphate (ADP) divided by the rate when the phosphate acceptor has been utilized and is no longer available (12, 13) . In the experimental system used, carefully prepared heart mitochondria from normal rats have RC values between 3 and 5. High values indicate that oxidation of substrate proceeds only in close association with the production of energy-rich phosphate compounds. The P/O ratio and the RC value obtained under various conditions often, but not necessarily, vary in parallel. Mitochondria with low RC values (the lowest possible being 1) or low P/O ratios (the lowest being 0) are said to be "uncoupled" (11) .
Materials and Methods
Chemical Compounds. Reagents of highest available grade were obtained from commercial sources and were prepared in glass-distilled water. Nagarse proteinase was obtained from the Enzyme Development Corporation, New York, N. Y. L-epinephrine bitartrate, L-norepinephrine bitartrate, L-isoproterenol bitartrate, and dihydroxyphenethylamine hydrochloride (dopamine) were suspended in peanut oil (1 mg of base/ml) for subcutaneous injection. Phenoxybenzamine hydrochloride was prepared in propylene glycol (17 mg of the hydrochloride/ml). 1-isopropylamino-3-(1-naphthyloxy) -2-propanol hydrochloride was obtained as propranolol from Ayerst Laboratories in ampules containing 5 mg/ml. Reserpine was prepared in propylene glycol (1 mg of free base/ml) (14) .
Un this paper the authors use ^atom to mean the atomic weight of oxygen expressed in micrograms.
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Procedures in Animals. Male Sprague-Dawley rats (250-350 g) were treated according to one of the following regimens. (1) In control experiments they were given 0.5 ml of peanut oil by subcutaneous injection 6 hours before they were killed. (2) In experiments designed to show the effect of catecholamine administration on oxidative phosphorylation, one dose of epinephrine, isoproterenol, norepinephrine, or dopamine in oil, 5 mg of base/kg, was given by subcutaneous injection at the indicated time (usually 6 hours) before death. The vehicle, route, and dosage were chosen to achieve prolonged elevated tissue levels of catecholamine and because previous studies have shown the consistent development of cardiomyopathy under these conditions (8) . (3) In experiments designed to show the influence of dibenzyline on the effects produced by catecholamines, a dose of 7 mg/kg dibenzyline was given by subcutaneous injection 24 and 48 hours before administration of a catecholamine. In other experiments designed to show the effect produced by dibenzyline alone, no subsequent catecholamine was given. (4) In experiments designed to show the influence of propranolol on the effects produced by catecholamine, doses of 1 mg/kg of propranolol were injected intraperitoneally every 2 hours, beginning 30 min before administration of catecholamine for a total of 4 doses. The effect of propranolol alone was evaluated by omitting the catecholamine. (5) In experiments designed to show the effect of catecholamine when myocardial uptake was blocked, 1 mg/kg reserpine was injected intraperitoneally 20 hours and 4 hours before administration of catecholamine.
Physiologic indices were studied in several animals treated with catecholamines. Arterial blood gases were measured polarographically with an Instrumentation Laboratories Polarograph. Arterial blood pressure was measured by cannulation of the carotid artery in animals anesthetized with 25 mg/kg pentobarbital given intraperitoneally. A Statham transducer and direct writing Sanborn recorder were used.
Preparation of Mitochondria. For each study of oxidative phosphorylation in heart mitochondria, it was necessary to pool the ventricular myocardium obtained from 3 to 5 rats. Mitochondria were prepared by modifications of the methods of Cleland and Slater and of Hagihara (15, 16) . The animals were decapitated. The hearts were rapidly removed and washed in homogenizing fluid containing .30 M sucrose and .001 M neutralized ethylenediaminetetraacetic acid (EDTA). Throughout the preparative procedure pH was adjusted with tris(hydroxymethyl)aminomethane (Tris) of the desired pH in a final concentration in each case of 0.001 M. The heart tissue was minced through a muscle press with holes 1 mm in diameter. It was then incubated with Nagarse proteinase, 1 mg/mL, in homogenizing fluid (pH 8.2) for 5 min (1 vol/g of tissue mash). This mixture was subsequently diluted 1:10 with homogenizing fluid at pH 7.4 and homogenized for 1 min in a loose-fitting Potter-Elvehjem homogenizer at 1000 rpm. The homogenate was centrifuged at 1400 X g for 6 min, the precipitated cell debris discarded, and the supernatant fraction centrifuged for 7 min at 10,000 X g. The supernatant fraction from this centrifugation was discarded. The precipitated mitochondrial pellet was suspended in homogenizing solution (with no Tris) with the aid of a glass stirring rod and repeated aspiration through a capillary pipette. Centrifugation at 10,000 X g was repeated, and the washed mitochondrial pellet was finally suspended in homogenizing solution (Tris was omitted in order to avoid interference with subsequent protein assay). The entire preparative procedure was carried out at 0°C.
Determination of P/O Ratio, RC, and Oxygen Consumption in the Mitochondrial Preparations.
Oxidative phosphorylation was studied polarographically by the method of Chance and Williams (17) using a Clark oxygen electrode in an essentially closed cuvette. The mitochondria (approximately 2 mg of mitochondrial protein) were incubated in a medium containing .25 M sucrose, .001 M EDTA, .01 M Tris pH 7.4, 7.5 mM potassium phosphate buffer pH 7.4, and 0.01 M substrate at 25°C. After oxygen consumption reached a steady state, 10 or 20 /^liters of .025 M ADP was injected through the capillary sidearm of the cuvette. Such an addition was associated with an increase in oxygen consumption which proceeded at a higher rate until the ADP was fully utilized. At that time the rate of oxygen consumption returned to a rate similar to the initial one. The high rate divided by the subsequent low rate was used to calculate RC. From the amount of oxygen consumed at the higher rate when a known amount of ADP was added, the P/O ratio was calculated. Oxygen consumption, qO 2 (//atoms of oxygen consumed per milligram of mitochondrial protein per minute), was calculated from the maximum rate when ADP was present. Serial additions of ADP could be made in this system as long as each was delayed until the oxygen consumption had returned to that characteristic of the mitochondria without phosphate acceptor. This allowed for multiple determinations of the P/O ratio during one incubation. Figure 1 shows curves typical of those on which calculations were based. All ADP solutions were assayed spectrophotometrically at 259 mfx using a molar extinction coefficient of 15.4 X 10» ( 1 8 ) .
Mitochondrial Protein, ATPase Activity, Swelling and Fatty Acid Content. Mitochondrial protein was determined by the biuret method after addition of 3% deoxycholic acid (final concentration 0.558) to an aliquot of the mitochondrial suspension (19) . ATPase activity was determined by measuring the amount of inorganic phosphate liberated from ATP during 10 min of incubation at 25°C. The incubation medium contained approximately 2 mg of mitochondrial protein, 6 yxmoles of ATP, 50 /xmoles of Tris pH 7.4, and 250 /xmoles of sucrose in a volume of 1 ml (20) . Phosphate was measured by a modification of the method of Martin and Doty (21) .
Mitochondrial swelling was determined by measuring the optical density at 520 mfi of Polarographic determination of oxidative phosphorylation: left = mitochondria from the hearts of normal rats; right = mitochondria from the hearts of rats treated with epinephrine (5mg/kg). Incubations were in a final volume of 2 ml as described in the text. Single and double vertical slashes indicate additions of . 25 and .50 yjnoles of ADP, respectively. Calibration of the oxygen electrode was based on the calculated value of initial oxygen content (indicated on the ordinate) in isotonic solutions equilibrated with room air at 25'C (17) . dilute mitochondrial suspensions following incubation of the mitochondria in 1 ml of 0.25 M sucrose for 10 min at 25°C, by which time absorbancy was stable (22) . Results were expressed as absorbancy at 520 mfi/mg of protein per ml.
Analysis of mitochondrial lipid content was performed as follows. Mitochondria from 10 rats were pooled. Since heptadecanoic acid does not occur in subcellular particles to any significant extent (23), a known quantity of this material was used as a fatty acid standard to provide a basis for calculation of the recovery of free fatty acid. A chloroform-methanol (2:1) extract of the tissue plus the fatty acid standard was made (24) and evaporated to dryness. Lipids were taken up in peroxide-free diethyl ether-hexane (1:1 v/v), an aliquot of which was used for thin layer chromatography. The remainder of the extract was treated with silicic acid (Bio-Rad, 325 mesh) to remove phospholipids (25) . After silicic acid adsorption, the extract was dried and taken up in 2,2,4-trimethylpentane. Free fatty acids were first separated from the remaining lipids by the Borgstrom procedure (26) and then methylated with borontrifluoride-methanol (14% w/v) (27) . The methyl esters formed were measured by gas-liquid chromatography using a 6-foot, 15!? polyethylene glycol succinate column (180°C) in an Electronic Instruments for Research gas chromatograph equipped with an ionization detector. Solvents were washed with acid and then with alkali before distillation, and glassware was washed with acid to remove interfering impurities. Calculations based on the observed recovery of heptadecanoic acid indicated that detection of as little as 0.1 jug of free fatty acid in the mitochondria isolated from one rat heart was well within the limits of sensitivity of the method.
Measurement of Myocardial Catecholamines.
Myocardial norepinephrine and epinephrine were measured by the spectrofluorometric method of Crout et al. (28) . Dopamine in cardiac tissue was measured by a modification of the method described by Carlsson and Waldeck (29) .
Result* EFFECT OF CATECHOLAMINES IN VIVO AND IN VITRO ON OXIDATIVE PHOSPHORYLATION
The results of measurements of oxidative phosphorylation in mitochondria isolated from normal rats and from rats treated 4 to 28 hours with epinephrine, norepinephrine, or isoproterenol are presented in Table 1 . Curves representative of those from which the numerical values were derived are shown in Figure 1 . The mean P/O ratio for mitochondria from treated animals was significantly lower ( P < .001) than that of mitochondria from normal animals; RC and qO L » were similar in both groups. Several experiments in which dopamine in oil (5 mg/kg) was administered showed that there was no decrease of the P/O ratio associated with the administration of this agent.
As shown in Table 2 , the same catecholamines that produced depression of the P/O ratio did not affect normal rat heart mitochondria in vitro at a concentration of
STUDIES OF THE MECHANISM OF THE CATECHOLAMINE EFFECT

Myocardial Catecholamine Content and
Depression of the P/O Ratio. The levels of epinephrine and norepinephrine in the myocardium at various times after a single dose of epinephrine (5 mg/kg) are shown in Figure 2 . It can be seen that there is good correspondence between elevation of myocardial catecholamine level and depression of the P/O ratio (uncoupling) in mitochondria obtained from animals treated similarly. Several other observations showed the same correlation. Administration of either norepinephrine or epinephrine was associated with comparable elevation of total myocardial catecholamines and Myocardial catecholamines and oxidative phosphorylation following administration of epinephrine (5 mg/kg) in vivo (mean ± SE). comparable depression of the P/O ratio. Dop-ministration of one dose of epinephrine. amine in vivo did not lead to elevation of Though neither propranolol nor dibenzyline catecholamines nor did it uncouple mitochon-alone affected the P/O, propranolol consistdrial metabolism. Table 3 gives results of ently enhanced the increase in myocardial studies in which propranolol, dibenzyline, and catecholamines after epinephrine administrareserpine pretreatment were followed by ad-tion and was associated with marked depres- *P/O ratios represent the mean values obtained with preparations from animals treated identically to those whose hearts were analyzed for catecholamine content.
Effect of Adrenergic Blocking Agents and Catecholamines in Vivo on Myocardial Catecholamine Content and Mitochondrial P/O Ratios
t These values were taken from Table 1 . Treatment and pretreatment regimens are described in text. Oxidative phosphorylation was studied at least twice during each treatment regimen. NE = norepinephrine; E = epinephrine. * Norepinephrine, epinephrine, and isoproterenol were administered 4 to 8 hours before the animals were killed, except in experiments 10 and 11, in which the drug was given 24 and 26 hours before. fStaristical analysis was done by Student's t-test. n j . = not significant. Each numbered experiment represents a separate preparation of mitochondria; each line represents the results obtained during one incubation; each value represents the average of all determinations made during a single incubation (usually 4). For statistical analysis, one average value was taken for each variable for an entire preparation, regardless of the number of incubations. sion of the P/O in mitochondria. Dibenzyline appeared to inhibit the increase in myocardial epinephrine (total catecholamines in the myocardium not differing significantly from the control animals) and inhibited depression of the P/O. Reserpine depleted myocardial catecholamines, markedly inhibited the net uptake of epinephrine, and inhibited the depression of the P/O ratio. Thus, these data show an association between elevation of myocardial catecholamine level and depression of the P/O.
Physiologic Indices in Animals Treated with Catecholamines. To evaluate the possibility that the observed effect of catecholamines on oxidative phosphorylation was due simply to morbidity or hypertension, blood pressure and blood gases were measured. There was no striking deviation from normal in blood pressure, pulse rate, arterial blood oxygen tension, carbon dioxide tension, and pH in the treated animals ( Table 4 ). This confirmed the apparent lack of correlation between the degree of morbidity exhibited by a given group of animals and the degree of uncoupling observed in mitochondria isolated from their hearts.
Since hypertension was not produced by isoproterenol treatment but depression of the P/O was, hypertension was not a necessary condition for the production of the catecholamine effect. That it was not a sufficient condition either was shown in studies of rats with renovascular hypertension 2 in which the P/O ratios of cardiac mitochondria were normal.
Effect of Catecholamines in Vivo on Mitochondrial Free Fatty Acids. Recent investigations by Ferrans et al. (30) and earlier observations by others (7, 8) have shown that lipid deposition, often in close proximity to mitochondria, occurs in the myocardium soon after the administration of catecholamines in doses such as those used in this study. Furthermore, the elevation of circulating free fatty acids by catecholamines is well known (31, 32) . In view of these observations and the known uncoupling effect of free fatty acids (11) , mitochondrial lipid content was determined in heart mitochondria from catecholamine-treated animals and from controls. Two experiments were done. Neither showed any difference in the amount of free fatty acid recoverable from the two groups of mitochondria. In both experiments the calculated recovery was approximately 60$ and the calculated maximum free fatty acid content of mitochondria from either group of animals was less than 4 X l(y /xmoles of mitochondrial free fatty acid per heart. This value is "•These animals were kindly prepared by Dr. John V. O. Reid. Hypertension was produced by application of a ligature to the right renal artery. Six weeks later, when mean blood pressure was increased an average of 30 mm Hg compared to preoperative values, the animals were killed and the mitochondria were studied. more suggestive of some hydrolysis of lipids during the extraction procedure than of a functionally significant mitochondrial fraction of free fatty acid. Thin layer chromatography with standard polar and nonpolar solvent systems (33) showed no difference in the lipid profiles of the two groups of mitochondria and confirmed the absence of a free fatty acid fraction in either group. The lipid profiles and the absence of a free fatty acid component are consistent with published observations concerning normal heart mitochondria (23) .
Effect of Catecholamines in Vitro on ATPase Activity and Mitochondrial Swelling. Evidence suggesting that the mitochondria from animals treated with catecholamines were not indiscriminately damaged is presented in Table 5 . No striking differences were noted between the ATPase activity of mitochondria from normal animals and those from treated animals. In several experiments in which normal mitochondria were incubated with epinephrine in vitro (ICHM final concentration), ATPase activity was not increased.
As shown in Figure 3 , there was no apparent difference between mitochondria from control animals and those from treated animals with respect to absorbancy at 520 m/x. Swollen mitochondria show a marked decrease in absorbancy, due to light scattering (22) , and Effect of catecholamines in vivo on mitochondrial swelling. Rat heart mitochondria from epinephrine treated (•), isoproterenol treated (A), norepinephrine treated (u) and normal (o) rats. The experimental procedure is described in the text. 'Animals from which heart mitochondria were isolated were treated with the indicated drug as described in the text.
tATPase activity was measured as described in the text, with and without magnesium in the assay medium. P, = inorganic phosphate. the generation of a single curve by mitochondria from the two groups suggests that there was no gross morphological difference after incubation between them (34) .
Effect of Adrenergic Blocking Agents and Other Compounds on Mitochondria in Vitro. As shown in Table 6 , neither dibenzyline nor propranolol in vitro affected the depressed P/O ratio of heart mitochondria from catecholamine-treated animals. Likewise, albumin, which improves impaired oxidative phosphorylation in vitro in mitochrondria uncoupled by fatty acids (35) or by aging (36) , failed to alter the depressed P/O ratios of mitochondria from catecholamine-treated animals. As shown in Table 2 , normal mitochondria were not affected by adrenergic blocking agents, adenosine-3',5'-cyclic phosphate (cyclic AMP), or by catecholamines in vitro.
Discussion
The results obtained in these studies indicate that a single, large subcutaneous dose of epinephrine, norepinephrine, or isoproterenol in oil produces uncoupling of oxidative phosphorylation in rat heart mitochondria, but that the same amines in vitro do not affect normal rat heart mitochondria. There was good correlation between elevation of total myocardial catecholamines and depression of the P/O ratio under various conditions and at various times following administration of the catecholamines.
Although the mechanism responsible for the observed effect was not conclusively demonstrated, evidence was obtained against several possibilities. Possible hypoxia, congestive heart failure, or elevated myocardial free fatty acid levels resulting from catecholamine administration might be considered responsible for the observed uncoupling of oxidative phosphorylation. Cardiac hypoxia leads to decreased respiratory control, increased ATPase activity, and swelling of mitochondria (37) . However, catecholamine-treated animals had essentially normal blood gases and their heart mitochondria showed no abnormality of RC, ATPase activity, or swelling compared to controls. Uncoupling of oxidative phosphorylation has been observed in heart mitochondria isolated from animals with chronic, though not acute, congestive heart failure (38) . However, this has not been universally found (39, 40) and has not been confirmed by preliminary studies in this laboratory. Furthermore, animals treated with catecholamines in the present study generally showed no evidence of gross congestive failure. If fatty acids were responsible for the depressed P/O ratios observed after catecholamine administration, one would anticipate increased fatty acid levels in the isolated mitochondria. Analysis showed that such was not the case. In addition, failure of albumin to improve oxidative phosphorylation in mitochondria from treated animals suggests that free fatty acids were not responsible. Although other lipid changes, such as changes in esterified fatty acids, may occur in the mitochondria following catecholamine administration in vivo, the studies by thin layer chromatography failed to reveal any gross alteration in the mitochondria! lipid profile. It thus appears that the observed catecholamine effect on oxidative phosphorylation is not due to hypoxia, congestive heart failure, or accumulation of free fatty acids. 
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The lack of effect of catecholamines in vitro on normal mitochondria and of adrenergic blocking agents in vitro on mitochondria from animals treated with catecholamines implies that the amines themselves do not directly alter mitochondrial function. Park et al. have shown that adrenochrome can uncouple oxidative phosphorylation in hamster liver mitochondria (41) . It is possible that adrenochrome or one of the metabolites known to be produced in association with elevated myocardial catecholamines is responsible for the observed effect. During this study we observed that liver mitochondria from animals treated with catecholamines were not uncoupled. This suggests that a circulating metabolite is less likely to be responsible for the depressed P/O ratios in heart mitochondria than one either produced in the myocardium or sequestered there.
The relationship between elevated myocardial catecholamine level and uncoupling of oxidative phosphorylation is of particular interest. As noted by others (42, 43) , we found that exogenous epinephrine depleted the myocardium of norepinephrine. However, since reserpine effectively depleted myocardial norepinephrine and blocked net uptake of epinephrine without producing uncoupling, depletion of norepinephrine does not explain the uncoupling effect observed. Propranolol alone did not deplete myocardial catecholamines or effect oxidative phosphorylation. However, it surprisingly potentiated the uptake of epinephrine and the associated depletion of norepinephrine following administration of epinephrine in vivo. This unexpected finding correlated well with the equally unexpected finding that propranolol potentiated the uncoupling of oxidative phosphorylation in heart mitochondria following epinephrine administration. The effects of dibenzyline and of reserpine on the P/O ratios and myocardial catecholamine levels following epinephrine administration were similar. Depression of the P/O ratio did not occur nor did elevation of total myocardial catecholamines (44) . These observations support the concept that the uncoupling of oxidative phosphorylation is close-CircmUlio* Rutrcb, Vol. XIX, Dtctmier 1966 ly related to the elevation of myocardial catecholamines.
A novel finding in our study was that the uncoupling manifested by depressed P/O ratios was not associated with depression of the RC values obtained. It is generally accepted that RC and the P/O ratio are two indices of the same fundamental mitochondrial mechanism responsible for the coupling of oxidation to phosphorylation. The dissociation between the two indices noted here is difficult to explain, since in vitro studies with uncoupling agents such as dinitrophenol show depressed RC with even lower concentrations of the agent than those required to depress the P/O ratio, and since aging of mitochondria is associated with impairment of RC before P/O ratio depression. Our finding of normal RC in association with depressed P/O ratios may indicate that despite precautions taken in preparing the mitochondria, damage affecting mitochondria from both normal and experimental animals may have led to some depression of the RC. An alternative explanation is that the catecholamine effect is such that it impairs mitochondrial function differently than known uncoupling agents active in vitro at a coupling site affecting the P/O ratio but not critical to RC. Of the three known coupling sites, it is not yet clear which is crucial to the phenomenon of respiratory control or whether in fact any one is specifically limiting. Another possibility for the apparent paradox is that the impairment of mitochondrial function produced by catecholamines is related to the presence of ADP, perhaps interacting with a metabolite accumulating in the mitochondria following treatment of the animals.
The uncoupling of oxidative phosphorylation in heart mitochondria produced by catecholamines in vivo perhaps contributes to the "oxygen wasting" seen in certain experimental conditions (1, 2) and to the increased basal metabolic rate of patients with pheochromocytoma. This impairment of energy metabolism might well contribute to the development of the catecholamine-induced cardiomyopathy seen in animals (5, 6) and in man (9, 10) . Clarification of the precise mechanism by which catecholamines produce uncoupling may increase understanding of normal mitochondrial function and the conditions required to maintain it.
